Company · CIK 1718852
Prometheus Biosciences, Inc.
| CIK | 1718852 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-05-13 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-264091 | 2022-04-01 | 2022-12-09 | 3 | |
| 333-253323 | 2021-02-19 | 2021-03-12 | 5 |
Filings
9| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2022-12-09 | 424B5Shelf takedown | 333-264091 | 0001193125-22-301821 |
| 2022-12-07 | 424B5Shelf takedown | 333-264091 | 0001193125-22-300151 |
| 2022-04-01 | S-3ASRShelf registered | 333-264091 | 0001193125-22-093851 |
| 2021-03-12 | 424B4Final prospectus | 333-253323 | 0001193125-21-079877 |
| 2021-03-11 | EFFECTDeclared effective | 333-253323 | 9999999995-21-000917 |
| 2021-03-11 | S-1/AAmendment | 333-253323 | 0001193125-21-076931 |
| 2021-03-08 | S-1/AAmendment | 333-253323 | 0001193125-21-072143 |
| 2021-02-19 | S-1Registration filed | 333-253323 | 0001193125-21-049126 |
| 2020-08-28 | DRSDraft made public | 377-03475 | 0000950123-20-009427 |